Literature DB >> 19418034

[Nosocomial infections: MRSA und CDAD as a challenge].

W V Kern1, M Dettenkofer.   

Abstract

Inadequate antibiotic prescribing and poor adherence to infection control guidelines are the main reasons for the development and spread of methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (CD), the most important cause of antibiotic-associated diarrhoea (AD) and colitis. Both CDAD and MRSA infection are associated with significant morbidity, excess mortality and substantial consumption of resources. Increases in the incidence of both infections have been observed in Germany and represent a challenge to clinicians, infection control practitioners, quality management teams und hospital administration. Prudent use of antibiotics, in particular critical prescribing of fluoroquinolones and cephalosporins, is an important component in programmes aiming at an effective prevention of MRSA and CDAD. Other similarly important components are minimization of pathogen transmission between patients and healthcare personnel by isolation and contact precautions, early detection of MRSA carriers and MRSA decolonization treatment. It must be ascertained that patients nursed in isolation rooms receive medical care of similar high quality as all other patients. Over the last years, there has been no major breakthrough in therapy and outcomes in both CDAD and MRSA infection. Close collaboration between hospitals, nursing homes and primary care institutions will be critical for better control of MRSA and CDAD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19418034     DOI: 10.1007/s00108-009-2389-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  43 in total

1.  [MRSA and other multi-resistant pathogens: an ever increasing problem even in ambulant medicine].

Authors:  M Dettenkofer; A F Widmer; W V Kern
Journal:  Dtsch Med Wochenschr       Date:  2008-02       Impact factor: 0.628

Review 2.  Interventions to control MRSA: high time for time-series analysis?

Authors:  S Harbarth; M H Samore
Journal:  J Antimicrob Chemother       Date:  2008-06-12       Impact factor: 5.790

Review 3.  Antimicrobial stewardship programs: interventions and associated outcomes.

Authors:  Dimple Patel; Wendy Lawson; B Joseph Guglielmo
Journal:  Expert Rev Anti Infect Ther       Date:  2008-04       Impact factor: 5.091

4.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

5.  Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection.

Authors:  John J Engemann; Yehuda Carmeli; Sara E Cosgrove; Vance G Fowler; Melissa Z Bronstein; Sharon L Trivette; Jane P Briggs; Daniel J Sexton; Keith S Kaye
Journal:  Clin Infect Dis       Date:  2003-02-07       Impact factor: 9.079

Review 6.  Clinical review of the management of fulminant clostridium difficile infection.

Authors:  M Raffat Jaber; Snorri Olafsson; Wesley L Fung; Mark E Reeves
Journal:  Am J Gastroenterol       Date:  2008-10-01       Impact factor: 10.864

Review 7.  The missing care bundle: antibiotic prescribing in hospitals.

Authors:  Fiona J Cooke; Alison H Holmes
Journal:  Int J Antimicrob Agents       Date:  2007-05-11       Impact factor: 5.283

8.  Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.

Authors:  Wafa N Al-Nassir; Ajay K Sethi; Michelle M Nerandzic; Greg S Bobulsky; Robin L P Jump; Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2008-07-01       Impact factor: 9.079

9.  Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea.

Authors:  Mark H Wilcox; Jane Freeman; Warren Fawley; Sarah MacKinlay; Alex Brown; Katrina Donaldson; Oliver Corrado
Journal:  J Antimicrob Chemother       Date:  2004-05-26       Impact factor: 5.790

Review 10.  Systematic review of antimicrobial drug prescribing in hospitals.

Authors:  Peter Davey; Erwin Brown; Lynda Fenelon; Roger Finch; Ian Gould; Alison Holmes; Craig Ramsay; Eric Taylor; Phil Wiffen; Mark Wilcox
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

View more
  1 in total

1.  The prevalence of nosocomial and community acquired infections in a university hospital: an observational study.

Authors:  Ella Ott; Svenja Saathoff; Karolin Graf; Frank Schwab; Iris F Chaberny
Journal:  Dtsch Arztebl Int       Date:  2013-08-05       Impact factor: 5.594

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.